206 related articles for article (PubMed ID: 31328883)
21. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
Andrade AF; Borges KS; Suazo VK; Geron L; Corrêa CA; Castro-Gamero AM; de Vasconcelos EJ; de Oliveira RS; Neder L; Yunes JA; Dos Santos Aguiar S; Scrideli CA; Tone LG
Invest New Drugs; 2017 Feb; 35(1):26-36. PubMed ID: 27785591
[TBL] [Abstract][Full Text] [Related]
22. The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma.
Sarić N; Selby M; Ramaswamy V; Kool M; Stockinger B; Hogstrand C; Williamson D; Marino S; Taylor MD; Clifford SC; Basson MA
Sci Rep; 2020 Jan; 10(1):148. PubMed ID: 31924815
[TBL] [Abstract][Full Text] [Related]
23. Follicle-restricted compartmentalization of transforming growth factor beta superfamily ligands in the feline ovary.
Bristol SK; Woodruff TK
Biol Reprod; 2004 Mar; 70(3):846-59. PubMed ID: 14656728
[TBL] [Abstract][Full Text] [Related]
24. Signaling pathway and molecular subgroups of medulloblastoma.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma.
Cormerais Y; Pagnuzzi-Boncompagni M; Schrötter S; Giuliano S; Tambutté E; Endou H; Wempe MF; Pagès G; Pouysségur J; Picco V
J Cell Mol Med; 2019 Apr; 23(4):2711-2718. PubMed ID: 30784173
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma stem cells.
Fan X; Eberhart CG
J Clin Oncol; 2008 Jun; 26(17):2821-7. PubMed ID: 18539960
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
28. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
[TBL] [Abstract][Full Text] [Related]
29. Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma.
Keating J; Tsoli M; Hallahan AR; Ingram WJ; Haber M; Ziegler DS
Mol Cancer Ther; 2012 Dec; 11(12):2654-63. PubMed ID: 23012247
[TBL] [Abstract][Full Text] [Related]
30. Activin ligands are required for the re-activation of Smad2 signalling after neurulation and vascular development in Xenopus tropicalis.
Nagamori Y; Roberts S; Maciej M; Dorey K
Int J Dev Biol; 2014; 58(10-12):783-91. PubMed ID: 26154320
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.
Markowitz D; Powell C; Tran NL; Berens ME; Ryken TC; Vanan M; Rosen L; He M; Sun S; Symons M; Al-Abed Y; Ruggieri R
Mol Cancer Ther; 2016 Aug; 15(8):1799-808. PubMed ID: 27207779
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
33. Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.
Guo D; Wang Y; Cheng Y; Liao S; Hu J; Du F; Xu G; Liu Y; Cai KQ; Cheung M; Wainwright BJ; Lu QR; Zhao Y; Yang ZJ
J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34254999
[TBL] [Abstract][Full Text] [Related]
34. PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.
Luo Y; Li M; Pratap UP; Viswanadhapalli S; Liu J; Venkata PP; Altwegg KA; Palacios BE; Li X; Chen Y; Rao MK; Brenner AJ; Sareddy GR; Vadlamudi RK
Mol Carcinog; 2020 Mar; 59(3):281-292. PubMed ID: 31872914
[TBL] [Abstract][Full Text] [Related]
35. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
Ferrucci V; de Antonellis P; Pennino FP; Asadzadeh F; Virgilio A; Montanaro D; Galeone A; Boffa I; Pisano I; Scognamiglio I; Navas L; Diana D; Pedone E; Gargiulo S; Gramanzini M; Brunetti A; Danielson L; Carotenuto M; Liguori L; Verrico A; Quaglietta L; Errico ME; Del Monaco V; D'Argenio V; Tirone F; Mastronuzzi A; Donofrio V; Giangaspero F; Picard D; Remke M; Garzia L; Daniels C; Delattre O; Swartling FJ; Weiss WA; Salvatore F; Fattorusso R; Chesler L; Taylor MD; Cinalli G; Zollo M
Brain; 2018 May; 141(5):1300-1319. PubMed ID: 29490009
[TBL] [Abstract][Full Text] [Related]
36. Biological Role and Therapeutic Targeting of TGF-β
Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M
Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490
[TBL] [Abstract][Full Text] [Related]
37. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Aug; 16(2):373-9. PubMed ID: 16820918
[TBL] [Abstract][Full Text] [Related]
38. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
39. TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma.
Santhana Kumar K; Neve A; Guerreiro Stucklin AS; Kuzan-Fischer CM; Rushing EJ; Taylor MD; Tripolitsioti D; Behrmann L; Kirschenbaum D; Grotzer MA; Baumgartner M
Cell Rep; 2018 Jun; 23(13):3798-3812.e8. PubMed ID: 29949765
[TBL] [Abstract][Full Text] [Related]
40. Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.
Billing M; Rörby E; Dahl M; Blank U; Andradottír S; Ehinger M; Karlsson S
Exp Hematol; 2017 Nov; 55():34-44.e2. PubMed ID: 28666967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
